On a frigid Norwegian afternoon earlier this month, Dan Quintana, a psychology professor at the University of Oslo, decided to stay in and complete a tedious task that he had been putting off for ...
Driven by both institutional mistrust and the need to go viral, Epstein theories are clogging up TikTok.
The Crosetto Foundation for the Reduction of Cancer Deaths, acting on its mission to provide cost-effective life-saving solutions to the public, calls for an immediate comparative scientific review to ...
A majority of counties experienced growth in penetration of Medicare value-based approaches: Medicare Shared Savings Program (MSSP) accountable care organizations (ACOs) and Medicare Advantage (MA).
Our findings indicate that a large commercial insurer is increasingly covering acupuncture for its beneficiaries. Unlike Medicare Part B, which limits acupuncture coverage to chronic low back pain, ...
Introduction A significant proportion of adults in England and Wales report experiencing childhood trauma, which is often associated with poor health and negative social outcomes including a ...
Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.
People from the Outer Hebrides and north-west Ireland have the highest risk of developing a genetic disease that causes a dangerous build-up of iron in the body, a study suggests. The study marks the ...
Evolving toxicity assessments for engineered nanoparticles underline the importance of predictive models and life-cycle risk ...
Beauty R&D is shifting toward “materials intelligence,” using AI and atom-level simulation to model ingredient interactions, cut trial-and-error, reduce waste, and speed the development of safer, ...
A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...
Safety signals spanning decades have not removed many high-risk psychiatric drugs from the market, prompting renewed scrutiny of federal regulators ...